Summary

The global Neuroendovascular Coil market is projected to grow from US$ 1373 million in 2025 to US$ 1861 million by 2032, at a CAGR of 4.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Neuroendovascular Coil refers to an implantable neurointerventional device delivered through a microcatheter into an intracranial aneurysm or other eligible neurovascular lesion, where it is deployed and controllably detached to promote mechanical packing, blood-flow reduction, thrombosis, and durable occlusion. The product is typically manufactured from radiopaque and biocompatible platinum or platinum-alloy materials and is supplied as a sterile single-use coil integrated with a delivery and detachment structure. Commercial products are differentiated by treatment role, including framing, filling, finishing, and multi-stage coils; by technology, including bare-metal and hydrogel-modified designs; and by secondary geometry, softness, detachment mechanism, primary coil diameter, expanded diameter, and coil length. The principal clinical application is endovascular embolization of intracranial aneurysms, while selected products are also indicated for other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The market focuses on coils specifically commercialized for neuroendovascular embolization and their integral delivery components.
Key Findings
Intracranial aneurysm embolization remains the principal clinical demand base for Neuroendovascular Coil
Bare-metal coils remain the mainstream technology, while hydrogel-modified coils provide a differentiated high-value product segment
Product competition increasingly centers on conformability, softness, packing efficiency, deliverability, and controlled detachment performance
The competitive structure combines established multinational neurointerventional platforms with increasingly capable Asian manufacturers
Market Trends
Neuroendovascular Coil development is shifting from basic mechanical occlusion toward more refined control of aneurysm framing, filling density, wall apposition, finishing performance, and procedural predictability. Manufacturers are expanding complex three-dimensional geometries, softer distal structures, broader diameter and length matrices, and designs optimized for increasingly low-profile microcatheters. Product portfolios are also becoming more procedure-specific, with dedicated framing, filling, finishing, and multi-stage coils enabling physicians to select different mechanical characteristics during a single intervention. Bare platinum and platinum-alloy coils continue to form the core of commercial portfolios, while hydrogel-modified technologies provide an alternative approach to increasing effective packing volume. Mechanical and electrically controlled detachment systems coexist, with development focused on faster, more predictable release and reduced catheter movement. Over the longer term, coil innovation is increasingly integrated with adjunctive stents, balloons, microcatheters, flow-diversion platforms, and other aneurysm-treatment technologies, reinforcing the importance of complete neurointerventional portfolios rather than individual coil products alone.
Market Dynamics
Drivers
Demand for Neuroendovascular Coil is supported by the established role of endovascular embolization in intracranial aneurysm management, broader availability of neurointerventional treatment, improved cerebrovascular imaging and diagnosis, and continued expansion of specialized stroke and neurovascular centers. The consumable nature of the product creates recurring procedural demand, while individual aneurysm procedures may require multiple coils with different sizes, shapes, and softness levels. Expansion of neurointerventional capabilities in emerging healthcare systems and broader physician familiarity with coil-based techniques further support underlying demand.
Restraints
Market expansion is constrained by pricing pressure from hospital procurement systems, reimbursement controls, centralized purchasing, and increasing competition among clinically comparable coil portfolios. Alternative aneurysm-treatment technologies, particularly flow diverters and intrasaccular flow-disruption devices, are changing treatment selection for certain aneurysm anatomies and can reduce the addressable coil requirement in selected procedures. High regulatory requirements for implantable neurovascular devices, clinical validation costs, quality-control requirements, and the need to maintain extensive inventories across numerous coil specifications also raise operating costs and market-entry barriers.
Opportunities
Growth opportunities are concentrated in differentiated coils that improve conformability, packing efficiency, softness, microcatheter compatibility, and procedural control, as well as in markets where neurointerventional penetration remains below mature-market levels. Hydrogel-modified coils, advanced complex-shape coils, ultra-soft finishing products, and optimized mechanical detachment systems provide opportunities for premium product positioning. Additional potential comes from integrated aneurysm-treatment portfolios combining coils with microcatheters, coil-assist stents, balloons, and access devices, enabling manufacturers to deepen hospital relationships and capture a larger share of procedural expenditure. Local manufacturing and broader regulatory approvals also create opportunities for Asian manufacturers to expand beyond domestic markets.
Challenges
The principal long-term challenge is maintaining meaningful product differentiation in a market where established coil technologies are clinically mature and competing systems increasingly offer broad specification coverage. Manufacturers must demonstrate consistent deployment behavior, detachment reliability, radiopacity, softness, and packing performance while maintaining high manufacturing yields across very small precision components. Physician preference and procedural experience create significant switching barriers, while hospital inventory requirements make comprehensive SKU coverage important for commercial adoption. At the same time, manufacturers must respond to evolving treatment algorithms in which coils may be used alone, with adjunctive devices, or replaced by alternative aneurysm-treatment technologies depending on anatomy and clinical strategy.
Industry Chain Analysis
The upstream Neuroendovascular Coil supply chain centers on implant-grade platinum and platinum-alloy wire, specialty stainless-steel and polymer components, hydrogel or other functional materials for modified coils, precision delivery components, detachment elements, sterile packaging materials, and contract sterilization services. Midstream manufacturing requires micro-wire processing, precision winding, secondary-shape forming, heat setting, joining, delivery-system assembly, detachment-system integration, inspection, cleanroom assembly, packaging, and sterilization. Product value is created primarily through coil geometry design, material engineering, precision manufacturing consistency, detachment reliability, clinical validation, regulatory approval, and the ability to supply a comprehensive specification matrix rather than through raw-material value alone. Downstream distribution extends through direct manufacturer sales and authorized distribution channels to hospitals, stroke centers, neurointerventional centers, and specialist physicians. Profitability therefore depends on product mix, manufacturing yield, regulatory access, hospital penetration, physician adoption, channel structure, procurement pricing, and the ability to generate recurring sales across a broad coil portfolio.
Segment Insights
By technology, bare-metal coils remain the principal commercial category because of their established clinical use, broad specification coverage, and availability across nearly all major manufacturers, while hydrogel-modified coils form a smaller differentiated segment focused on increasing effective filling volume. By treatment role, the market is structured around framing, filling, finishing, and multi-stage products, reflecting the sequential mechanical requirements of aneurysm packing. Three-dimensional complex coils are particularly important for stable framing and spatial distribution, while helical and softer structures are widely used for filling and finishing. Standard, soft, and extra-soft products provide additional differentiation according to support and conformability. Electrical and mechanical detachment represent the two principal release technologies. Specification competition extends across primary coil diameter, expanded diameter, and coil length, making portfolio breadth an important commercial advantage because hospitals require multiple configurations to address diverse aneurysm morphology.
Downstream Market Opportunities
Intracranial aneurysm treatment represents the central downstream opportunity for Neuroendovascular Coil, particularly in hospitals and neurovascular centers with established endovascular treatment capabilities. Demand is increasingly shaped by the need to manage small, irregular, wide-neck, recurrent, and anatomically complex aneurysms using customized combinations of framing, filling, and finishing coils, sometimes together with adjunctive stents or balloons. Broader neurointerventional infrastructure in emerging markets creates additional procedure-volume potential, while mature markets provide opportunities for premium technologies that improve packing efficiency, deliverability, and procedural predictability. Selected products also address other neurovascular embolization procedures, including arteriovenous malformations and arteriovenous fistulae, although intracranial aneurysm embolization remains the dominant application.
Regional Insights
North America and Europe remain mature, high-value Neuroendovascular Coil markets characterized by extensive neurointerventional infrastructure, established physician adoption, broad availability of premium coil portfolios, and strong participation by multinational manufacturers. Japan is distinguished by a sophisticated neuroendovascular clinical base and the presence of domestic manufacturers alongside global suppliers. Asia-Pacific has become a central competitive and expansion arena, driven by rising procedural capability, broader product registration, and the increasing commercial scale of Chinese neurointerventional manufacturers. China combines substantial procedure demand with centralized procurement and strong domestic competition, creating greater pricing pressure while accelerating local product adoption. India and Southeast Asia offer longer-term expansion opportunities as neurointerventional treatment capacity develops, whereas market access in Latin America, the Middle East, and Africa remains more dependent on distributor networks, regulatory registration, and concentration of advanced procedures in major medical centers.
Competitive Landscape Analysis
The Neuroendovascular Coil market combines global neurointerventional platforms with a growing group of Asian manufacturers. Stryker, Medtronic, Johnson & Johnson, Terumo, Penumbra, Balt, Kaneka, and Wallaby Medical compete through established physician relationships, broad coil specification matrices, international regulatory coverage, and complementary aneurysm-treatment portfolios. Genesis MedTech and Meril Life Sciences provide additional Asian participation outside China, while MicroPort NeuroScientific, Peijia Medical, Shanghai HeartCare Medical Technology, Zylox-Tonbridge Medical Technology, Beijing Taijieweiye Technology, Shandong Weigao Interventional Medical Technology, and Hunan Ricoton Technology strengthen competition from China. Competitive differentiation increasingly depends on framing stability, softness, packing efficiency, microcatheter compatibility, detachment reliability, specification breadth, clinical evidence, and access to hospital purchasing channels. Multinational companies retain advantages in global clinical networks and portfolio breadth, while Chinese manufacturers benefit from local regulatory experience, manufacturing economics, domestic hospital coverage, and expanding neurointerventional product portfolios. Competitive intensity is therefore increasingly determined by the ability to combine technical performance with a complete procedural ecosystem, sustainable pricing, and geographic market access.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Neuroendovascular Coil market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Stryker Corporation
Medtronic plc
Johnson & Johnson
Terumo Corporation
Penumbra, Inc.
Balt Group
Kaneka Corporation
Wallaby Medical Holding, Inc.
Genesis MedTech Group Limited
Meril Life Sciences Pvt. Ltd.
MicroPort NeuroScientific Corporation
Peijia Medical Limited
Shanghai HeartCare Medical Technology Corporation Limited
Zylox-Tonbridge Medical Technology Co., Ltd.
Beijing Taijieweiye Technology Co., Ltd.
Shandong Weigao Interventional Medical Technology Co., Ltd.
Hunan Ricoton Technology Development Co., Ltd.
Segment by Type
Framing Coils
Filling Coils
Finishing Coils
Multi-Stage Coils
Segment by Coil Technology
Bare Metal Coils
Hydrogel-Modified Coils
Others
Segment by Detachment Mechanism
Electrical Detachment Coils
Mechanical Detachment Coils
Segment by Application
Intracranial Aneurysm Embolization
Arteriovenous Malformation Embolization
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Neuroendovascular Coil study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Neuroendovascular Coil: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Neuroendovascular Coil Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Framing Coils
1.2.3 Filling Coils
1.2.4 Finishing Coils
1.2.5 Multi-Stage Coils
1.3 Market Segmentation by Coil Technology
1.3.1 Global Neuroendovascular Coil Market Size by Coil Technology, 2021 vs 2025 vs 2032
1.3.2 Bare Metal Coils
1.3.3 Hydrogel-Modified Coils
1.3.4 Others
1.4 Market Segmentation by Detachment Mechanism
1.4.1 Global Neuroendovascular Coil Market Size by Detachment Mechanism, 2021 vs 2025 vs 2032
1.4.2 Electrical Detachment Coils
1.4.3 Mechanical Detachment Coils
1.5 Market Segmentation by Application
1.5.1 Global Neuroendovascular Coil Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Intracranial Aneurysm Embolization
1.5.3 Arteriovenous Malformation Embolization
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Neuroendovascular Coil Revenue Estimates and Forecasts (2021-2032)
2.2 Global Neuroendovascular Coil Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Neuroendovascular Coil Sales Estimates and Forecasts (2021-2032)
2.4 Global Neuroendovascular Coil Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Neuroendovascular Coil Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Neuroendovascular Coil Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Framing Coils: Market Share by Key Manufacturers
3.5.2 Filling Coils: Market Share by Key Manufacturers
3.5.3 Finishing Coils: Market Share by Key Manufacturers
3.5.4 Multi-Stage Coils: Market Share by Key Manufacturers
3.6 Global Neuroendovascular Coil Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Neuroendovascular Coil Sales Performance by Type
4.1.1 Global Neuroendovascular Coil Sales Volume by Type (2021-2032)
4.1.2 Global Neuroendovascular Coil Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Neuroendovascular Coil Sales Performance by Coil Technology
4.2.1 Global Neuroendovascular Coil Sales Volume by Coil Technology (2021-2032)
4.2.2 Global Neuroendovascular Coil Revenue by Coil Technology (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Coil Technology (2021-2032)
4.3 Global Neuroendovascular Coil Sales Performance by Detachment Mechanism
4.3.1 Global Neuroendovascular Coil Sales Volume by Detachment Mechanism (2021-2032)
4.3.2 Global Neuroendovascular Coil Revenue by Detachment Mechanism (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Detachment Mechanism (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Neuroendovascular Coil Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Neuroendovascular Coil Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Neuroendovascular Coil Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Neuroendovascular Coil Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Neuroendovascular Coil Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Neuroendovascular Coil Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Neuroendovascular Coil Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Neuroendovascular Coil Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Neuroendovascular Coil Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Neuroendovascular Coil Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Neuroendovascular Coil Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Neuroendovascular Coil Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Stryker Corporation
11.1.1 Stryker Corporation Corporation Information
11.1.2 Stryker Corporation Business Overview
11.1.3 Stryker Corporation Neuroendovascular Coil Product Models, Descriptions and Specifications
11.1.4 Stryker Corporation Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Stryker Corporation Neuroendovascular Coil Sales by Product in 2025
11.1.6 Stryker Corporation Neuroendovascular Coil Sales by Application in 2025
11.1.7 Stryker Corporation Neuroendovascular Coil Sales by Geographic Area in 2025
11.1.8 Stryker Corporation Neuroendovascular Coil SWOT Analysis
11.1.9 Stryker Corporation Recent Developments
11.2 Medtronic plc
11.2.1 Medtronic plc Corporation Information
11.2.2 Medtronic plc Business Overview
11.2.3 Medtronic plc Neuroendovascular Coil Product Models, Descriptions and Specifications
11.2.4 Medtronic plc Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Medtronic plc Neuroendovascular Coil Sales by Product in 2025
11.2.6 Medtronic plc Neuroendovascular Coil Sales by Application in 2025
11.2.7 Medtronic plc Neuroendovascular Coil Sales by Geographic Area in 2025
11.2.8 Medtronic plc Neuroendovascular Coil SWOT Analysis
11.2.9 Medtronic plc Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Neuroendovascular Coil Product Models, Descriptions and Specifications
11.3.4 Johnson & Johnson Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Johnson & Johnson Neuroendovascular Coil Sales by Product in 2025
11.3.6 Johnson & Johnson Neuroendovascular Coil Sales by Application in 2025
11.3.7 Johnson & Johnson Neuroendovascular Coil Sales by Geographic Area in 2025
11.3.8 Johnson & Johnson Neuroendovascular Coil SWOT Analysis
11.3.9 Johnson & Johnson Recent Developments
11.4 Terumo Corporation
11.4.1 Terumo Corporation Corporation Information
11.4.2 Terumo Corporation Business Overview
11.4.3 Terumo Corporation Neuroendovascular Coil Product Models, Descriptions and Specifications
11.4.4 Terumo Corporation Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Terumo Corporation Neuroendovascular Coil Sales by Product in 2025
11.4.6 Terumo Corporation Neuroendovascular Coil Sales by Application in 2025
11.4.7 Terumo Corporation Neuroendovascular Coil Sales by Geographic Area in 2025
11.4.8 Terumo Corporation Neuroendovascular Coil SWOT Analysis
11.4.9 Terumo Corporation Recent Developments
11.5 Penumbra, Inc.
11.5.1 Penumbra, Inc. Corporation Information
11.5.2 Penumbra, Inc. Business Overview
11.5.3 Penumbra, Inc. Neuroendovascular Coil Product Models, Descriptions and Specifications
11.5.4 Penumbra, Inc. Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Penumbra, Inc. Neuroendovascular Coil Sales by Product in 2025
11.5.6 Penumbra, Inc. Neuroendovascular Coil Sales by Application in 2025
11.5.7 Penumbra, Inc. Neuroendovascular Coil Sales by Geographic Area in 2025
11.5.8 Penumbra, Inc. Neuroendovascular Coil SWOT Analysis
11.5.9 Penumbra, Inc. Recent Developments
11.6 Balt Group
11.6.1 Balt Group Corporation Information
11.6.2 Balt Group Business Overview
11.6.3 Balt Group Neuroendovascular Coil Product Models, Descriptions and Specifications
11.6.4 Balt Group Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Balt Group Recent Developments
11.7 Kaneka Corporation
11.7.1 Kaneka Corporation Corporation Information
11.7.2 Kaneka Corporation Business Overview
11.7.3 Kaneka Corporation Neuroendovascular Coil Product Models, Descriptions and Specifications
11.7.4 Kaneka Corporation Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Kaneka Corporation Recent Developments
11.8 Wallaby Medical Holding, Inc.
11.8.1 Wallaby Medical Holding, Inc. Corporation Information
11.8.2 Wallaby Medical Holding, Inc. Business Overview
11.8.3 Wallaby Medical Holding, Inc. Neuroendovascular Coil Product Models, Descriptions and Specifications
11.8.4 Wallaby Medical Holding, Inc. Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Wallaby Medical Holding, Inc. Recent Developments
11.9 Genesis MedTech Group Limited
11.9.1 Genesis MedTech Group Limited Corporation Information
11.9.2 Genesis MedTech Group Limited Business Overview
11.9.3 Genesis MedTech Group Limited Neuroendovascular Coil Product Models, Descriptions and Specifications
11.9.4 Genesis MedTech Group Limited Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Genesis MedTech Group Limited Recent Developments
11.10 Meril Life Sciences Pvt. Ltd.
11.10.1 Meril Life Sciences Pvt. Ltd. Corporation Information
11.10.2 Meril Life Sciences Pvt. Ltd. Business Overview
11.10.3 Meril Life Sciences Pvt. Ltd. Neuroendovascular Coil Product Models, Descriptions and Specifications
11.10.4 Meril Life Sciences Pvt. Ltd. Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Meril Life Sciences Pvt. Ltd. Recent Developments
11.11 MicroPort NeuroScientific Corporation
11.11.1 MicroPort NeuroScientific Corporation Corporation Information
11.11.2 MicroPort NeuroScientific Corporation Business Overview
11.11.3 MicroPort NeuroScientific Corporation Neuroendovascular Coil Product Models, Descriptions and Specifications
11.11.4 MicroPort NeuroScientific Corporation Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 MicroPort NeuroScientific Corporation Recent Developments
11.12 Peijia Medical Limited
11.12.1 Peijia Medical Limited Corporation Information
11.12.2 Peijia Medical Limited Business Overview
11.12.3 Peijia Medical Limited Neuroendovascular Coil Product Models, Descriptions and Specifications
11.12.4 Peijia Medical Limited Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Peijia Medical Limited Recent Developments
11.13 Shanghai HeartCare Medical Technology Corporation Limited
11.13.1 Shanghai HeartCare Medical Technology Corporation Limited Corporation Information
11.13.2 Shanghai HeartCare Medical Technology Corporation Limited Business Overview
11.13.3 Shanghai HeartCare Medical Technology Corporation Limited Neuroendovascular Coil Product Models, Descriptions and Specifications
11.13.4 Shanghai HeartCare Medical Technology Corporation Limited Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Shanghai HeartCare Medical Technology Corporation Limited Recent Developments
11.14 Zylox-Tonbridge Medical Technology Co., Ltd.
11.14.1 Zylox-Tonbridge Medical Technology Co., Ltd. Corporation Information
11.14.2 Zylox-Tonbridge Medical Technology Co., Ltd. Business Overview
11.14.3 Zylox-Tonbridge Medical Technology Co., Ltd. Neuroendovascular Coil Product Models, Descriptions and Specifications
11.14.4 Zylox-Tonbridge Medical Technology Co., Ltd. Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Zylox-Tonbridge Medical Technology Co., Ltd. Recent Developments
11.15 Beijing Taijieweiye Technology Co., Ltd.
11.15.1 Beijing Taijieweiye Technology Co., Ltd. Corporation Information
11.15.2 Beijing Taijieweiye Technology Co., Ltd. Business Overview
11.15.3 Beijing Taijieweiye Technology Co., Ltd. Neuroendovascular Coil Product Models, Descriptions and Specifications
11.15.4 Beijing Taijieweiye Technology Co., Ltd. Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Beijing Taijieweiye Technology Co., Ltd. Recent Developments
11.16 Shandong Weigao Interventional Medical Technology Co., Ltd.
11.16.1 Shandong Weigao Interventional Medical Technology Co., Ltd. Corporation Information
11.16.2 Shandong Weigao Interventional Medical Technology Co., Ltd. Business Overview
11.16.3 Shandong Weigao Interventional Medical Technology Co., Ltd. Neuroendovascular Coil Product Models, Descriptions and Specifications
11.16.4 Shandong Weigao Interventional Medical Technology Co., Ltd. Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Shandong Weigao Interventional Medical Technology Co., Ltd. Recent Developments
11.17 Hunan Ricoton Technology Development Co., Ltd.
11.17.1 Hunan Ricoton Technology Development Co., Ltd. Corporation Information
11.17.2 Hunan Ricoton Technology Development Co., Ltd. Business Overview
11.17.3 Hunan Ricoton Technology Development Co., Ltd. Neuroendovascular Coil Product Models, Descriptions and Specifications
11.17.4 Hunan Ricoton Technology Development Co., Ltd. Neuroendovascular Coil Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Hunan Ricoton Technology Development Co., Ltd. Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Neuroendovascular Coil Industry Chain
12.2 Neuroendovascular Coil Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Neuroendovascular Coil Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Neuroendovascular Coil Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Neuroendovascular Coil Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Neuroendovascular Coil Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Neuroendovascular Coil Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Neuroendovascular Coil Market Size Growth Rate by Coil Technology, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Neuroendovascular Coil Market Size Growth Rate by Detachment Mechanism, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Neuroendovascular Coil Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Neuroendovascular Coil Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Neuroendovascular Coil Revenue by Region (US$ Million), 2021-2026
Table 7. Global Neuroendovascular Coil Revenue by Region (US$ Million), 2027-2032
Table 8. Global Neuroendovascular Coil Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Neuroendovascular Coil Sales by Region (K Units), 2021-2026
Table 10. Global Neuroendovascular Coil Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Neuroendovascular Coil Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Neuroendovascular Coil Sales Share by Manufacturers (2021-2026)
Table 14. Global Neuroendovascular Coil Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Neuroendovascular Coil Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Neuroendovascular Coil Revenue, 2025
Table 18. Global Neuroendovascular Coil Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Neuroendovascular Coil Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 20. Key Manufacturers Neuroendovascular Coil Manufacturing Base and Headquarters
Table 21. Global Neuroendovascular Coil Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Neuroendovascular Coil Sales Volume by Type (K Units), 2021-2026
Table 25. Global Neuroendovascular Coil Sales Volume by Type (K Units), 2027-2032
Table 26. Global Neuroendovascular Coil Revenue by Type (US$ Million), 2021-2026
Table 27. Global Neuroendovascular Coil Revenue by Type (US$ Million), 2027-2032
Table 28. Global Neuroendovascular Coil Sales Volume by Coil Technology (K Units), 2021-2026
Table 29. Global Neuroendovascular Coil Sales Volume by Coil Technology (K Units), 2027-2032
Table 30. Global Neuroendovascular Coil Revenue by Coil Technology (US$ Million), 2021-2026
Table 31. Global Neuroendovascular Coil Revenue by Coil Technology (US$ Million), 2027-2032
Table 32. Global Neuroendovascular Coil Sales Volume by Detachment Mechanism (K Units), 2021-2026
Table 33. Global Neuroendovascular Coil Sales Volume by Detachment Mechanism (K Units), 2027-2032
Table 34. Global Neuroendovascular Coil Revenue by Detachment Mechanism (US$ Million), 2021-2026
Table 35. Global Neuroendovascular Coil Revenue by Detachment Mechanism (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Neuroendovascular Coil Sales by Application (K Units), 2021-2026
Table 38. Global Neuroendovascular Coil Sales by Application (K Units), 2027-2032
Table 39. Neuroendovascular Coil High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Neuroendovascular Coil Revenue by Application (US$ Million), 2021-2026
Table 41. Global Neuroendovascular Coil Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Neuroendovascular Coil Growth Accelerators and Market Barriers
Table 45. North America Neuroendovascular Coil Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Neuroendovascular Coil Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Neuroendovascular Coil Growth Accelerators and Market Barriers
Table 48. Europe Neuroendovascular Coil Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Neuroendovascular Coil Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Neuroendovascular Coil Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Neuroendovascular Coil Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Neuroendovascular Coil Growth Accelerators and Market Barriers
Table 53. Southeast Asia Neuroendovascular Coil Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Neuroendovascular Coil Investment Opportunities and Key Challenges
Table 55. Central and South America Neuroendovascular Coil Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Neuroendovascular Coil Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Neuroendovascular Coil Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Stryker Corporation Corporation Information
Table 59. Stryker Corporation Description and Major Businesses
Table 60. Stryker Corporation Product Models, Descriptions and Specifications
Table 61. Stryker Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 62. Stryker Corporation Sales Value Proportion by Product in 2025
Table 63. Stryker Corporation Sales Value Proportion by Application in 2025
Table 64. Stryker Corporation Sales Value Proportion by Geographic Area in 2025
Table 65. Stryker Corporation Neuroendovascular Coil SWOT Analysis
Table 66. Stryker Corporation Recent Developments
Table 67. Medtronic plc Corporation Information
Table 68. Medtronic plc Description and Major Businesses
Table 69. Medtronic plc Product Models, Descriptions and Specifications
Table 70. Medtronic plc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Medtronic plc Sales Value Proportion by Product in 2025
Table 72. Medtronic plc Sales Value Proportion by Application in 2025
Table 73. Medtronic plc Sales Value Proportion by Geographic Area in 2025
Table 74. Medtronic plc Neuroendovascular Coil SWOT Analysis
Table 75. Medtronic plc Recent Developments
Table 76. Johnson & Johnson Corporation Information
Table 77. Johnson & Johnson Description and Major Businesses
Table 78. Johnson & Johnson Product Models, Descriptions and Specifications
Table 79. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Johnson & Johnson Sales Value Proportion by Product in 2025
Table 81. Johnson & Johnson Sales Value Proportion by Application in 2025
Table 82. Johnson & Johnson Sales Value Proportion by Geographic Area in 2025
Table 83. Johnson & Johnson Neuroendovascular Coil SWOT Analysis
Table 84. Johnson & Johnson Recent Developments
Table 85. Terumo Corporation Corporation Information
Table 86. Terumo Corporation Description and Major Businesses
Table 87. Terumo Corporation Product Models, Descriptions and Specifications
Table 88. Terumo Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Terumo Corporation Sales Value Proportion by Product in 2025
Table 90. Terumo Corporation Sales Value Proportion by Application in 2025
Table 91. Terumo Corporation Sales Value Proportion by Geographic Area in 2025
Table 92. Terumo Corporation Neuroendovascular Coil SWOT Analysis
Table 93. Terumo Corporation Recent Developments
Table 94. Penumbra, Inc. Corporation Information
Table 95. Penumbra, Inc. Description and Major Businesses
Table 96. Penumbra, Inc. Product Models, Descriptions and Specifications
Table 97. Penumbra, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Penumbra, Inc. Sales Value Proportion by Product in 2025
Table 99. Penumbra, Inc. Sales Value Proportion by Application in 2025
Table 100. Penumbra, Inc. Sales Value Proportion by Geographic Area in 2025
Table 101. Penumbra, Inc. Neuroendovascular Coil SWOT Analysis
Table 102. Penumbra, Inc. Recent Developments
Table 103. Balt Group Corporation Information
Table 104. Balt Group Description and Major Businesses
Table 105. Balt Group Product Models, Descriptions and Specifications
Table 106. Balt Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Balt Group Recent Developments
Table 108. Kaneka Corporation Corporation Information
Table 109. Kaneka Corporation Description and Major Businesses
Table 110. Kaneka Corporation Product Models, Descriptions and Specifications
Table 111. Kaneka Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Kaneka Corporation Recent Developments
Table 113. Wallaby Medical Holding, Inc. Corporation Information
Table 114. Wallaby Medical Holding, Inc. Description and Major Businesses
Table 115. Wallaby Medical Holding, Inc. Product Models, Descriptions and Specifications
Table 116. Wallaby Medical Holding, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Wallaby Medical Holding, Inc. Recent Developments
Table 118. Genesis MedTech Group Limited Corporation Information
Table 119. Genesis MedTech Group Limited Description and Major Businesses
Table 120. Genesis MedTech Group Limited Product Models, Descriptions and Specifications
Table 121. Genesis MedTech Group Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Genesis MedTech Group Limited Recent Developments
Table 123. Meril Life Sciences Pvt. Ltd. Corporation Information
Table 124. Meril Life Sciences Pvt. Ltd. Description and Major Businesses
Table 125. Meril Life Sciences Pvt. Ltd. Product Models, Descriptions and Specifications
Table 126. Meril Life Sciences Pvt. Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Meril Life Sciences Pvt. Ltd. Recent Developments
Table 128. MicroPort NeuroScientific Corporation Corporation Information
Table 129. MicroPort NeuroScientific Corporation Description and Major Businesses
Table 130. MicroPort NeuroScientific Corporation Product Models, Descriptions and Specifications
Table 131. MicroPort NeuroScientific Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. MicroPort NeuroScientific Corporation Recent Developments
Table 133. Peijia Medical Limited Corporation Information
Table 134. Peijia Medical Limited Description and Major Businesses
Table 135. Peijia Medical Limited Product Models, Descriptions and Specifications
Table 136. Peijia Medical Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Peijia Medical Limited Recent Developments
Table 138. Shanghai HeartCare Medical Technology Corporation Limited Corporation Information
Table 139. Shanghai HeartCare Medical Technology Corporation Limited Description and Major Businesses
Table 140. Shanghai HeartCare Medical Technology Corporation Limited Product Models, Descriptions and Specifications
Table 141. Shanghai HeartCare Medical Technology Corporation Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Shanghai HeartCare Medical Technology Corporation Limited Recent Developments
Table 143. Zylox-Tonbridge Medical Technology Co., Ltd. Corporation Information
Table 144. Zylox-Tonbridge Medical Technology Co., Ltd. Description and Major Businesses
Table 145. Zylox-Tonbridge Medical Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 146. Zylox-Tonbridge Medical Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Zylox-Tonbridge Medical Technology Co., Ltd. Recent Developments
Table 148. Beijing Taijieweiye Technology Co., Ltd. Corporation Information
Table 149. Beijing Taijieweiye Technology Co., Ltd. Description and Major Businesses
Table 150. Beijing Taijieweiye Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 151. Beijing Taijieweiye Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Beijing Taijieweiye Technology Co., Ltd. Recent Developments
Table 153. Shandong Weigao Interventional Medical Technology Co., Ltd. Corporation Information
Table 154. Shandong Weigao Interventional Medical Technology Co., Ltd. Description and Major Businesses
Table 155. Shandong Weigao Interventional Medical Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 156. Shandong Weigao Interventional Medical Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Shandong Weigao Interventional Medical Technology Co., Ltd. Recent Developments
Table 158. Hunan Ricoton Technology Development Co., Ltd. Corporation Information
Table 159. Hunan Ricoton Technology Development Co., Ltd. Description and Major Businesses
Table 160. Hunan Ricoton Technology Development Co., Ltd. Product Models, Descriptions and Specifications
Table 161. Hunan Ricoton Technology Development Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Hunan Ricoton Technology Development Co., Ltd. Recent Developments
Table 163. Key Raw Materials Distribution
Table 164. Raw Materials Key Suppliers
Table 165. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 166. Milestones in Production Technology Evolution
Table 167. Distributors List
Table 168. Market Trends and Market Evolution
Table 169. Market Drivers and Opportunities
Table 170. Market Challenges, Risks, and Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources

List of Figures
Figure 1. Neuroendovascular Coil Product Picture
Figure 2. Global Neuroendovascular Coil Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Framing Coils Product Picture
Figure 4. Filling Coils Product Picture
Figure 5. Finishing Coils Product Picture
Figure 6. Multi-Stage Coils Product Picture
Figure 7. Global Neuroendovascular Coil Market Size Growth Rate by Coil Technology, 2021 vs 2025 vs 2032 (US$ Million)
Figure 8. Bare Metal Coils Product Picture
Figure 9. Hydrogel-Modified Coils Product Picture
Figure 10. Others Product Picture
Figure 11. Global Neuroendovascular Coil Market Size Growth Rate by Detachment Mechanism, 2021 vs 2025 vs 2032 (US$ Million)
Figure 12. Electrical Detachment Coils Product Picture
Figure 13. Mechanical Detachment Coils Product Picture
Figure 14. Global Neuroendovascular Coil Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Intracranial Aneurysm Embolization
Figure 16. Arteriovenous Malformation Embolization
Figure 17. Others
Figure 18. Neuroendovascular Coil Report Years Considered
Figure 19. Global Neuroendovascular Coil Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 21. Global Neuroendovascular Coil Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 22. Global Neuroendovascular Coil Revenue-Based Market Share by Region (2021-2032)
Figure 23. Global Neuroendovascular Coil Sales (K Units), 2021-2032
Figure 24. Global Neuroendovascular Coil Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 25. Global Neuroendovascular Coil Sales Market Share by Region (2021-2032)
Figure 26. Top 5 and Top 10 Manufacturers Neuroendovascular Coil Sales Volume Market Share in 2025
Figure 27. Global Neuroendovascular Coil Revenue-Based Market Share Ranking (2025)
Figure 28. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 29. Framing Coils Revenue-Based Market Share by Manufacturer in 2025
Figure 30. Filling Coils Revenue-Based Market Share by Manufacturer in 2025
Figure 31. Finishing Coils Revenue-Based Market Share by Manufacturer in 2025
Figure 32. Multi-Stage Coils Revenue-Based Market Share by Manufacturer in 2025
Figure 33. Global Neuroendovascular Coil Sales Volume-Based Market Share by Type (2021-2032)
Figure 34. Global Neuroendovascular Coil Revenue-Based Market Share by Type (2021-2032)
Figure 35. Global Neuroendovascular Coil ASP by Type (US$/Unit), 2021-2032
Figure 36. Global Neuroendovascular Coil Sales Volume-Based Market Share by Coil Technology (2021-2032)
Figure 37. Global Neuroendovascular Coil Revenue-Based Market Share by Coil Technology (2021-2032)
Figure 38. Global Neuroendovascular Coil ASP by Coil Technology (US$/Unit), 2021-2032
Figure 39. Global Neuroendovascular Coil Sales Volume-Based Market Share by Detachment Mechanism (2021-2032)
Figure 40. Global Neuroendovascular Coil Revenue-Based Market Share by Detachment Mechanism (2021-2032)
Figure 41. Global Neuroendovascular Coil ASP by Detachment Mechanism (US$/Unit), 2021-2032
Figure 42. Global Neuroendovascular Coil Sales Market Share by Application (2021-2032)
Figure 43. Global Neuroendovascular Coil Revenue-Based Market Share by Application (2021-2032)
Figure 44. Global Neuroendovascular Coil ASP by Application (US$/Unit), 2021-2032
Figure 45. North America Neuroendovascular Coil Sales YoY (K Units), 2021-2032
Figure 46. North America Neuroendovascular Coil Revenue YoY (US$ Million), 2021-2032
Figure 47. North America Top 5 Manufacturers Neuroendovascular Coil Sales Revenue (US$ Million) in 2025
Figure 48. North America Neuroendovascular Coil Sales Volume (K Units) by Application (2021-2032)
Figure 49. North America Neuroendovascular Coil Sales Revenue (US$ Million) by Application (2021-2032)
Figure 50. US Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 51. Canada Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 52. Mexico Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 53. Europe Neuroendovascular Coil Sales YoY (K Units), 2021-2032
Figure 54. Europe Neuroendovascular Coil Revenue YoY (US$ Million), 2021-2032
Figure 55. Europe Top 5 Manufacturers Neuroendovascular Coil Sales Revenue (US$ Million) in 2025
Figure 56. Europe Neuroendovascular Coil Sales Volume (K Units) by Application (2021-2032)
Figure 57. Europe Neuroendovascular Coil Sales Revenue (US$ Million) by Application (2021-2032)
Figure 58. Germany Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 59. France Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 60. U.K. Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 61. Italy Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 62. Russia Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 63. Asia-Pacific Neuroendovascular Coil Sales YoY (K Units), 2021-2032
Figure 64. Asia-Pacific Neuroendovascular Coil Revenue YoY (US$ Million), 2021-2032
Figure 65. Asia-Pacific Top 8 Manufacturers Neuroendovascular Coil Sales Revenue (US$ Million) in 2025
Figure 66. Asia-Pacific Neuroendovascular Coil Sales Volume (K Units) by Application (2021-2032)
Figure 67. Asia-Pacific Neuroendovascular Coil Sales Revenue (US$ Million) by Application (2021-2032)
Figure 68. Indonesia Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 69. Japan Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 70. South Korea Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 71. China Taiwan Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 72. India Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 73. Central and South America Neuroendovascular Coil Sales YoY (K Units), 2021-2032
Figure 74. Central and South America Neuroendovascular Coil Revenue YoY (US$ Million), 2021-2032
Figure 75. Central and South America Top 5 Manufacturers Neuroendovascular Coil Sales Revenue (US$ Million) in 2025
Figure 76. Central and South America Neuroendovascular Coil Sales Volume (K Units) by Application (2021-2032)
Figure 77. Central and South America Neuroendovascular Coil Sales Revenue (US$ Million) by Application (2021-2032)
Figure 78. Brazil Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 79. Argentina Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 80. Middle East, and Africa Neuroendovascular Coil Sales YoY (K Units), 2021-2032
Figure 81. Middle East and Africa Neuroendovascular Coil Revenue YoY (US$ Million), 2021-2032
Figure 82. Middle East and Africa Top 5 Manufacturers Neuroendovascular Coil Sales Revenue (US$ Million) in 2025
Figure 83. Middle East and Africa Neuroendovascular Coil Sales Volume (K Units) by Application (2021-2032)
Figure 84. Middle East and Africa Neuroendovascular Coil Sales Revenue (US$ Million) by Application (2021-2032)
Figure 85. GCC Countries Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 86. Turkey Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 87. Egypt Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 88. South Africa Neuroendovascular Coil Revenue (US$ Million), 2021-2032
Figure 89. Neuroendovascular Coil Industry Chain Mapping
Figure 90. Regional Neuroendovascular Coil Manufacturing Base Distribution (%)
Figure 91. Global Neuroendovascular Coil Production Market Share by Region (2021-2032)
Figure 92. Neuroendovascular Coil Production Process
Figure 93. Regional Neuroendovascular Coil Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed